Navigation Links
GOP's Big Pharma Protection to Cost NC Taxpayers "Hundreds of Millions"

RALEIGH, N.C., April 14, 2011 /PRNewswire-USNewswire/ -- Attorney General Roy Cooper warned the House Special Select Committee on Tort Reform today that a measure giving immunity to pharmaceutical companies could cost North Carolina taxpayers what one legislator described as "hundreds of millions of dollars."

Still, the GOP-controlled committee, led by Rep. Johnathan Rhyne, approved the controversial measure.  HB 542 could go to the House floor for a vote next week.

The stunning exchange occurred when Rep. Jennifer Weiss floated an amendment to remove the immunity measure for pharma companies that sell harmful drugs.  A member of Attorney General Cooper's staff then stood and expressed the concerns of the NC Department of Justice.  The AG's office later put those concerns -- related to Medicaid and the State Health Plan as well as consumer recovery -- into writing:

"North Carolina taxpayers and consumers could lose millions in legal settlements won because of illegal drug marketing and other violations if House Bill 542 becomes law ... North Carolina could become only the second state in the country where pharmaceutical manufacturers could be allowed to do or say anything about a drug as long as it has basic FDA approval."

Rep. Rhyne acknowledged talking to Attorney General Cooper, but brushed off the concerns with what consumer advocates argued was a dangerous misreading of a law in Michigan, the only state to have passed the extreme legislation under consideration in North Carolina.

"Republican leaders in the House are siding with corporate interests over everyday taxpayers," said Dick Taylor of the NC Advocates for Justice.  "That Republicans would choose to cost the state hundreds of millions of dollars to help pharmaceutical companies during such hard economic times is beyond perplexing.  

But even more disturbing is the fact that under this bill, North Carolinians -- like people in Michigan, but unlike the citizens of every other state -- would be totally unable to recover damages in cases of death or injury due to bad drugs.  The bill benefits multinational drug companies at the expense of North Carolina consumers, and does nothing to help the North Carolina economy."

Under Rep. Rhyne's bill, drug companies could not be sued by those harmed by defective and dangerous drugs unless the company obtained FDA approval by fraud or bribery.  Even if the product is later found to be harmful or deadly, the drug manufacturer -- so long as it had FDA approval -- cannot be held liable.  

For more information, please contact Todd(at)ncaj(dot)com. Follow our news on Facebook and on our website

SOURCE NC Advocates for Justice
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Oxford Finance Corporation Provides a $2 Million Equipment Facility to Synta Pharmaceuticals Corp.
2. Beacon Announces Agreement With New Fortune 500 Pharmaceutical Client
3. Novis Pharmaceuticals Celebrates Four Years With New Website Launch
4. Merz Pharmaceuticals Joins Patient Advocates to Raise Awareness of Cervical Dystonia and Blepharospasm
5. Patients -- Not ERs and Big Pharma -- Need Protection
6. Mpex Pharmaceuticals, Inc. to be Acquired by Axcan
7. NCPA Backs Bill to Enhance Pharmacy Competition; Help Level Playing Field for Independent Community Pharmacists
8. Talyst Signs Vendor Agreement With H. D. Smith to Provide Quality- and Patient Safety-Enhancing Pharmacy Automation Solutions
9. PharmAthene Completes Dosing in Valortim® Phase I Clinical Trial
10. ePharmaSolutions Launches Major Release of Its Global Safety Letter Distribution and Tracking Application in More Than 90 Countries
11. Cephalon Lodges Bidders Statement for A$167 Million Offer for ChemGenex Pharmaceuticals
Post Your Comments:
(Date:12/1/2015)... 01, 2015 ... the "Medium Molecular Weight Polyisobutylene Market ... Other Applications - Global Industry Analysis, Size, ... 2023" report to their offering. ... addition of the "Medium Molecular Weight ...
(Date:12/1/2015)... CLEVELAND , Dec. 1, 2015   ... innovation firm, today announced the publication of a ... Entering the Direct-to-Consumer Medical Market". The whitepaper gives ... roadmap for successfully penetrating this lucrative segment. ... purchase healthcare products to manage their own health, ...
(Date:12/1/2015)... 1, 2015 Array BioPharma Inc. ... its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public ... through a webcast on the Array BioPharma ... --> , ...
Breaking Medicine Technology:
(Date:12/1/2015)... (PRWEB) , ... December 02, 2015 , ... ... research “ Gastrointestinal events and association with initiation of treatment for osteoporosis ”. ... the use of pharmacological treatment in patients diagnosed with osteoporosis. Based on a ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... its acquisition by Jordan Industries International, LLC (“JII”). , With support from JII, ... and maintenance services to hospitals, surgery centers, clinics, research labs and medical facilities ...
(Date:12/1/2015)... ... , ... According to an article published on November 16th by ... U.S. Department of Health and Human Services, claiming that any states which do not ... clause in the law prohibiting the denial of coverage for pre-existing conditions. The article ...
(Date:12/1/2015)... ... December 01, 2015 , ... Baptist Medical Center Jacksonville ... is the only hospital in the region providing what is known as the ... pacing patients were revealed recently at a medical conference and published in The ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one of ... has been named by MedEsthetics magazine as the Best Single Physician Practice in the ... the many elite aesthetic physicians honored by the industry publication. , Dr. Vitenas ...
Breaking Medicine News(10 mins):